Publication | Open Access
A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients
52
Citations
13
References
2019
Year
Celecoxib combined with chemotherapy offers more clinical benefits for COX-2 positive advanced gastric cancer patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1